Article
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
19 Jul 2013
Abstract excerpt
About one-third of oestrogen receptor alpha-positive breast cancer patients treated with tamoxifen relapse. Here we identify the nuclear receptor retinoic acid receptor alpha as a marker of tamoxifen resistance. Using quantitative mass spectrometry-based proteomics, we show that retinoic acid receptor alpha protein networks and levels differ in a tamoxifen-sensitive (MCF7) and a tamoxifen-resistant (LCC2) cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
